Denali Therapeutics Inc
NASDAQ:DNLI
Denali Therapeutics Inc
NASDAQ:DNLI
Price:
20.65
USD
4.93%
Market Closed
Market Cap:
$3.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Denali Therapeutics Inc
NASDAQ:DNLI
|
US |
|
Banco Bilbao Vizcaya Argentaria SA
NYSE:BBVA
|
ES |
|
O
|
Observe Medical ASA
OSE:OBSRV
|
NO |
|
District Metals Corp
XTSX:DMX
|
CA |
Wall Street
Price Targets
DNLI Price Targets Summary
Denali Therapeutics Inc
Denali Therapeutics Inc
Wall Street analysts forecast DNLI stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
DNLI
is 33.59 USD
with a low forecast of 25.25 USD and a high forecast of 42 USD.
Lowest
Price Target
25.25
USD
22% Upside
Average
Price Target
33.59
USD
63% Upside
Highest
Price Target
42
USD
103% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DNLI's stock price target?
Price Target
33.59
USD
33.59
USD
According to Wall Street analysts, the average 1-year price target for
DNLI
is 33.59 USD
with a low forecast of 25.25 USD and a high forecast of 42 USD.
